TY - JOUR
T1 - Astin C Production by the Endophytic Fungus Cyanodermella asteris in Planktonic and Immobilized Culture Conditions
AU - Vassaux, Antoine
AU - Tarayre, Cédric
AU - Arguëlles-Arias, Anthony
AU - Compère, Philippe
AU - Delvigne, Frank
AU - Fickers, Patrick
AU - Jahn, Linda
AU - Lang, Alexander
AU - Leclère, Valérie
AU - Ludwig-Müller, Jutta
AU - Ongena, Marc
AU - Schafhauser, Thomas
AU - Telek, Samuel
AU - Théatre, Ariane
AU - van Berkel, Willem J.H.
AU - Vandenbol, Micheline
AU - van Pée, Karl Heinz
AU - Willems, Luc
AU - Wohlleben, Wolfgang
AU - Jacques, Philippe
PY - 2019/8/1
Y1 - 2019/8/1
N2 - The fungal endophyte Cyanodermella asteris (C. asteris) has been recently isolated from the medicinal plant Aster tataricus (A. tataricus). This fungus produces astin C, a cyclic pentapeptide with anticancer and anti-inflammatory properties. The production of this secondary metabolite is compared in immobilized and planktonic conditions. For immobilized cultures, a stainless steel packing immersed in the culture broth is used as a support. In these conditions, the fungus exclusively grows on the packing, which provides a considerable advantage for astin C recovery and purification. C. asteris metabolism is different according to the culture conditions in terms of substrate consumption rate, cell growth, and astin C production. Immobilized-cell cultures yield a 30% increase of astin C production, associated with a 39% increase in biomass. The inoculum type as spores rather than hyphae, and a pre-inoculation washing procedure with sodium hydroxide, turns out to be beneficial both for astin C production and fungus development onto the support. Finally, the influence of culture parameters such as pH and medium composition on astin C production is evaluated. With optimized culture conditions, astin C yield is further improved reaching a five times higher final specific yield compared to the value reported with astin C extraction from A. tataricus (0.89 mg g−1 and 0.16 mg g−1 respectively).
AB - The fungal endophyte Cyanodermella asteris (C. asteris) has been recently isolated from the medicinal plant Aster tataricus (A. tataricus). This fungus produces astin C, a cyclic pentapeptide with anticancer and anti-inflammatory properties. The production of this secondary metabolite is compared in immobilized and planktonic conditions. For immobilized cultures, a stainless steel packing immersed in the culture broth is used as a support. In these conditions, the fungus exclusively grows on the packing, which provides a considerable advantage for astin C recovery and purification. C. asteris metabolism is different according to the culture conditions in terms of substrate consumption rate, cell growth, and astin C production. Immobilized-cell cultures yield a 30% increase of astin C production, associated with a 39% increase in biomass. The inoculum type as spores rather than hyphae, and a pre-inoculation washing procedure with sodium hydroxide, turns out to be beneficial both for astin C production and fungus development onto the support. Finally, the influence of culture parameters such as pH and medium composition on astin C production is evaluated. With optimized culture conditions, astin C yield is further improved reaching a five times higher final specific yield compared to the value reported with astin C extraction from A. tataricus (0.89 mg g−1 and 0.16 mg g−1 respectively).
KW - astin C
KW - biofilms
KW - Cyanodermella asteris
KW - immobilized-cell cultures
KW - secondary metabolites
U2 - 10.1002/biot.201800624
DO - 10.1002/biot.201800624
M3 - Article
C2 - 31161690
AN - SCOPUS:85069863331
SN - 1860-6768
VL - 14
JO - Biotechnology Journal
JF - Biotechnology Journal
IS - 8
M1 - 1800624
ER -